Cargando…
Data Mining of Gene Arrays for Biomarkers of Survival in Ovarian Cancer
The expected five-year survival rate from a stage III ovarian cancer diagnosis is a mere 22%; this applies to the 7000 new cases diagnosed yearly in the UK. Stratification of patients with this heterogeneous disease, based on active molecular pathways, would aid a targeted treatment improving the pr...
Autores principales: | Coveney, Clare, Boocock, David J., Rees, Robert C., Deen, Suha, Ball, Graham R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996375/ https://www.ncbi.nlm.nih.gov/pubmed/27600227 http://dx.doi.org/10.3390/microarrays4030324 |
Ejemplares similares
-
A simpler method of preprocessing MALDI-TOF MS data for differential biomarker analysis: stem cell and melanoma cancer studies
por: Tong, Dong L, et al.
Publicado: (2011) -
Multiomic analysis of stretched osteocytes reveals processes and signalling linked to bone regeneration and cancer
por: Santos, Lívia, et al.
Publicado: (2021) -
Artificial Neural Network Inference (ANNI): A Study on Gene-Gene Interaction for Biomarkers in Childhood Sarcomas
por: Tong, Dong Ling, et al.
Publicado: (2014) -
High mobility group protein B1 is a predictor of poor survival in ovarian cancer
por: Machado, Lee R., et al.
Publicado: (2017) -
β2-Adrenergic Signalling Promotes Cell Migration by Upregulating Expression of the Metastasis-Associated Molecule LYPD3
por: Gruet, Michael, et al.
Publicado: (2020)